Targeting minimal residual disease: a path to cure?
Therapeutics that block kinases, transcriptional modifiers, immune checkpoints and other biological vulnerabilities are transforming cancer treatment. As a result, many patients achieve dramatic responses, including complete radiographical or pathological remission, yet retain minimal residual disea...
Main Authors: | Luskin, Marlise R., Murakami, Mark A., Weinstock, David M., Manalis, Scott R |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Biological Engineering |
Format: | Article |
Language: | en_US |
Published: |
Nature Publishing Group
2018
|
Online Access: | http://hdl.handle.net/1721.1/118912 https://orcid.org/0000-0001-5223-9433 |
Similar Items
-
Quiescent leukaemic cells account for minimal residual disease in childhood lymphoblastic leukaemia.
by: Lutz, C, et al.
Published: (2013) -
Sensitive Detection of Minimal Residual Disease in Patients Treated for Early-Stage Breast Cancer
by: Parsons, Heather A., et al.
Published: (2022) -
Fast Augmenting Paths by Random Sampling from Residual Graphs
by: Karger, David R., et al.
Published: (2015) -
Minimizing Residual Vibrations in Flexible Systems
by: Rappole, B. Whitney, Jr.
Published: (2004) -
Sensitive Detection of Minimal Residual Disease in Patients Treated for Early-Stage Breast Cancer
Published: (2021)